Diagnostic Accuracy of Periodontitis with Point of Care Test Device INCLIXTM TRF MMP-8 using Human Saliva: A Single Center, Single Blinded, Pivotal Study

Seoul National University Dental Hospital0 个研究点目标入组 300 人开始时间: 待定最近更新: 2022年10月24日

适应症

试验速览

暂无简介。

•1)subjects having received periodontal therapy within the previous 4 months.
•2) Subjects who have taken antibiotics within the previous 3 months.
•3) Subjects using immunosuppressants (methotrexate, leflunomide, tacrolimus, cyclosporin, azathioprine) or corticosteroids (oral or injection) within previous 3 months.
•4) Subjects with uncontrolled hypertension or diabetes.
•5) Subjects with serious cardiovascular disease, respiratory system disease, kidney disease, liver disease, digestive system disease, blood system disease, and/or neuropsychiatric disease complications.
•6) Subjects with hyperthyroidism or hypothyroidism.
•7) pregnancy.
•8) Subjects with autoimmune diseases.
•9) Subjects with a history or current malignant tumors in the maxilla or mandible.
•10) Subjects who have had or are current drugs abuse or alcohol addiction within previous 1 year.
•11) Subjects with ulcerative, bullous, or erosive stomatitis.
•12) Subjects with other inflammatory diseases in oral cavity, such as canker sores, herpes simplex and herpes zoster, fungal or bacterial infections except periodontitis.

发起方